Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26384238

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Oct
First author
Burnett AK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Oct;16(13):1274-5. doi: 10.1016/S1470-2045(15)00210-7.
    note
    Source null
    related pmid
    26384240
    relationship
    Comment in

Authors and identifiers

  1. name
    Burnett AK
    type
    Author
  2. name
    Russell NH
    type
    Author
  3. name
    Hills RK
    type
    Author
  4. name
    Bowen D
    type
    Author
  5. name
    Kell J
    type
    Author
  6. name
    Knapper S
    type
    Author
  7. name
    Morgan YG
    type
    Author
  8. name
    Lok J
    type
    Author
  9. name
    Grech A
    type
    Author
  10. name
    Jones G
    type
    Author
  11. name
    Khwaja A
    type
    Author
  12. name
    Friis L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burnett AK
    type
    Author
  2. name
    Russell NH
    type
    Author
  3. name
    Hills RK
    type
    Author
  4. name
    Bowen D
    type
    Author
  5. name
    Kell J
    type
    Author
  6. name
    Knapper S
    type
    Author
  7. name
    Morgan YG
    type
    Author
  8. name
    Lok J
    type
    Author
  9. name
    Grech A
    type
    Author
  10. name
    Jones G
    type
    Author
  11. name
    Khwaja A
    type
    Author
  12. name
    Friis L
    type
    Author
bibliography ids
  1. nci-bib-651ae221b771797b4532aa7d
book metadata
content sha256
14259a1c8c53bc243162d687709694265bf3361d119a4fbcbc143a78b7aeb625
document type
citation
dois
  1. 10.1016/S1470-2045(15)00193-X
electronic publication date
display
2015 Sep 14
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26384238
immutable id
pubmed:26384238@14259a1c8c53bc243162d687709694265bf3361d119a4fbcbc143a78b7aeb625
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
13
name
The Lancet. Oncology
nlm unique id
100957246
pages
1295-305
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Oct;16(13):1274-5. doi: 10.1016/S1470-2045(15)00210-7.
    note
    Source null
    related pmid
    26384240
    relationship
    Comment in
outcomes validated
false
pmid
26384238
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
e787b375345e8a1cbf1c2717884d42c03d6c952430e0f59beef10e93cb63ac7e
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Oct
precision
month
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26384238/
title
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.

Preserved source evidence · Not medical advice